These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 18768875)
1. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. Do TQ; Moshkani S; Castillo P; Anunta S; Pogosyan A; Cheung A; Marbois B; Faull KF; Ernst W; Chiang SM; Fujii G; Clarke CF; Foster K; Porter E J Immunol; 2008 Sep; 181(6):4177-87. PubMed ID: 18768875 [TBL] [Abstract][Full Text] [Related]
2. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic. Cheung Lam AH; Sandoval N; Wadhwa R; Gilkes J; Do TQ; Ernst W; Chiang SM; Kosina S; Howard Xu H; Fujii G; Porter E BMC Res Notes; 2016 Jul; 9():337. PubMed ID: 27391402 [TBL] [Abstract][Full Text] [Related]
3. Innate antimicrobial activity of nasal secretions. Cole AM; Dewan P; Ganz T Infect Immun; 1999 Jul; 67(7):3267-75. PubMed ID: 10377100 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis. Lee JT; Jansen M; Yilma AN; Nguyen A; Desharnais R; Porter E Am J Rhinol Allergy; 2010; 24(2):99-104. PubMed ID: 20338107 [TBL] [Abstract][Full Text] [Related]
5. Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients. Ma DC; Yoon AJ; Faull KF; Desharnais R; Zemanick ET; Porter E PLoS One; 2015; 10(4):e0125326. PubMed ID: 25919295 [TBL] [Abstract][Full Text] [Related]
6. Cationic polypeptides are required for antibacterial activity of human airway fluid. Cole AM; Liao HI; Stuchlik O; Tilan J; Pohl J; Ganz T J Immunol; 2002 Dec; 169(12):6985-91. PubMed ID: 12471133 [TBL] [Abstract][Full Text] [Related]
7. The antibacterial innate immune response by the mosquito Aedes aegypti is mediated by hemocytes and independent of Gram type and pathogenicity. Hillyer JF; Schmidt SL; Christensen BM Microbes Infect; 2004 Apr; 6(5):448-59. PubMed ID: 15109959 [TBL] [Abstract][Full Text] [Related]
8. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. Langer C; Huang Y; Cullen P; Wiesenhütter B; Mahley RW; Assmann G; von Eckardstein A J Mol Med (Berl); 2000; 78(4):217-27. PubMed ID: 10933584 [TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids. Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580 [TBL] [Abstract][Full Text] [Related]
10. Novel surface phase containing cholesteryl esters. 2. Nonequivalence of cholesteryl arachidonate and those with 18-carbon, cis-unsaturated acyl groups. Smaby JM; Brockman HL Biochemistry; 1981 Feb; 20(4):724-30. PubMed ID: 7213606 [TBL] [Abstract][Full Text] [Related]
11. Specificity of lipid transfer protein for molecular species of cholesteryl ester. Morton RE J Lipid Res; 1986 May; 27(5):523-9. PubMed ID: 3734635 [TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437 [TBL] [Abstract][Full Text] [Related]
13. Properties of cholesteryl esters in pure and mixed monolayers. Kwong CN; Heikkila RE; Cornwell DG J Lipid Res; 1971 Jan; 12(1):31-5. PubMed ID: 5542702 [TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177 [TBL] [Abstract][Full Text] [Related]
15. Bacterial adherence to nasal mucosal cells. Aly R; Shinefield HI; Strauss WG; Maibach HI Infect Immun; 1977 Sep; 17(3):546-9. PubMed ID: 409676 [TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Vieira O; Laranjinha J; Madeira V; Almeida L Biochem Pharmacol; 1998 Feb; 55(3):333-40. PubMed ID: 9484800 [TBL] [Abstract][Full Text] [Related]